Literature DB >> 25399584

The glioblastoma vasculature as a target for cancer therapy.

Anna Dimberg1.   

Abstract

Glioblastoma is characterized by microvascular proliferation and a highly abnormal dysfunctional vasculature. The glioblastoma vessels differ significantly from normal brain vessels morphologically, functionally and molecularly. The present review provides a brief overview of the current understanding of the formation, functional abnormalities and specific gene expression of glioblastoma vessels and the consequences of vascular abnormalization for the tumour microenvironment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25399584     DOI: 10.1042/BST20140278

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  20 in total

1.  Pleiotrophin is a driver of vascular abnormalization in glioblastoma.

Authors:  Lei Zhang; Anna Dimberg
Journal:  Mol Cell Oncol       Date:  2016-02-18

Review 2.  Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells.

Authors:  Raghupathy Vengoji; Moorthy P Ponnusamy; Satyanarayana Rachagani; Sidharth Mahapatra; Surinder K Batra; Nicole Shonka; Muzafar A Macha
Journal:  Carcinogenesis       Date:  2019-03-12       Impact factor: 4.944

3.  Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.

Authors:  Eggehard Holler; Tao Sun; Rameshwar Patil; Anna Galstyan; Dmytro Klymyshyn; Hui Ding; Alexandra Chesnokova; Webster K Cavenee; Frank B Furnari; Vladimir A Ljubimov; Ekaterina S Shatalova; Shawn Wagner; Debiao Li; Adam N Mamelak; Serguei I Bannykh; Chirag G Patil; Jeremy D Rudnick; Jethro Hu; Zachary B Grodzinski; Arthur Rekechenetskiy; Vida Falahatian; Alexander V Lyubimov; Yongmei L Chen; Lai S Leoh; Tracy R Daniels-Wells; Manuel L Penichet; Alexander V Ljubimov; Keith L Black; Julia Y Ljubimova
Journal:  Cancer Res       Date:  2019-01-18       Impact factor: 12.701

4.  IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment.

Authors:  Deborah Rotoli; Manuel Morales; María-Del-C Maeso; Julio Ávila; Natalia D Pérez-Rodríguez; Ali Mobasheri; Cornelis J F van Noorden; Pablo Martín-Vasallo
Journal:  J Histochem Cytochem       Date:  2019-02-22       Impact factor: 2.479

5.  Multiscale Modeling of Glioblastoma Suggests that the Partial Disruption of Vessel/Cancer Stem Cell Crosstalk Can Promote Tumor Regression Without Increasing Invasiveness.

Authors:  Huaming Yan; Monica Romero-Lopez; Hermann B Frieboes; Christopher C W Hughes; John S Lowengrub
Journal:  IEEE Trans Biomed Eng       Date:  2016-10-07       Impact factor: 4.538

6.  Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment.

Authors:  Eric Nyberg; Justin Honce; Bette K Kleinschmidt-DeMasters; Brian Shukri; Sarah Kreidler; Lidia Nagae
Journal:  Neuroradiol J       Date:  2016-08-19

7.  Quantitative imaging of pO2 in orthotopic murine gliomas: hypoxia correlates with resistance to radiation.

Authors:  Hironobu Yasui; Tatsuya Kawai; Shingo Matsumoto; Keita Saito; Nallathamby Devasahayam; James B Mitchell; Kevin Camphausen; Osamu Inanami; Murali C Krishna
Journal:  Free Radic Res       Date:  2017-10

8.  A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain.

Authors:  Ali Ghoochani; Eduard Yakubov; Tina Sehm; Zheng Fan; Stefan Hock; Michael Buchfelder; Ilker Y Eyüpoglu; Nicolai E Savaskan
Journal:  Oncotarget       Date:  2016-01-12

9.  Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches.

Authors:  Wen-Juan Huang; Wei-Wei Chen; Xia Zhang
Journal:  Oncol Lett       Date:  2016-08-04       Impact factor: 2.967

10.  Uncovering a Distinct Gene Signature in Endothelial Cells Associated With Contrast Enhancement in Glioblastoma.

Authors:  Fan Yang; Yuan Xie; Jiefu Tang; Boxuan Liu; Yuancheng Luo; Qiyuan He; Lingxue Zhang; Lele Xin; Jianhao Wang; Sinan Wang; Shuqiang Zhang; Qingze Cao; Liang Wang; Liqun He; Lei Zhang
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.